HIV 1 News and Research

RSS

OJ-Bio to showcase new smartphone-enabled diagnostic testing device at Medica 2015

Advanced smartphone-enabled medical device technology for the rapid and cost-effective detection of infectious diseases will be featured at this year’s prestigious Medica show.

29 Sep 2015

Unique molecule can bind HIV-infected cells to killer T cells

A unique molecule developed at Duke Medicine, the University of North Carolina at Chapel Hill and MacroGenics, Inc., is able to bind HIV-infected cells to the immune system's killer T cells. It could become a key part of a shock-and-kill strategy being developed in the hope of one day clearing HIV infection.

29 Sep 2015

Specialized proteins can inhibit HIV

There is little doubt that the Human Immunodeficiency Virus, or HIV, is devastating. More than 1.2 million people in the United States are living with HIV and more than 47,000 people are diagnosed annually. Now, University of Missouri researchers have made a discovery in how specialized proteins can inhibit the virus, opening the door for progress in the fight against HIV and for the production of advanced therapeutics to combat the disease.

29 Sep 2015

OJ Bio at Medica 2015 - Point of Care diagnostics' role in reducing antibiotics prescribing

Advanced smartphone-enabled medical device technology for the rapid and cost-effective detection of infectious diseases will be featured at this year’s prestigious Medica show.

28 Sep 2015

Investment in radiotherapy services could save lives, boost economy in developing countries

Millions of people are dying from potentially treatable cancers like breast and prostate because of a chronic underinvestment in radiotherapy resources, according to a major new Commission on access to radiotherapy, published in The Lancet Oncology, and being presented at the 2015 European Cancer Congress in Vienna, Austria.

26 Sep 2015

New partnership aims to support countries in improving performance of primary health care

Underscoring the urgent need to transform how essential health care is delivered in low- and middle-income countries, the Bill & Melinda Gates Foundation, World Bank Group and World Health Organization today are launching a new partnership to support countries in improving the performance of primary health care.

26 Sep 2015

Creating a new paradigm for management of yeast infections

Yeasts are unicellular microorganisms classified within the Fungi kingdom. They are well known for their use in baking, winemaking and beer brewing fermentation, but some species of yeast are opportunistic pathogens that can cause infections in humans. "Today, yeast infections are poorly understood, difficult to diagnose, and are becoming increasingly frequent and serious, affecting over 300 million people worldwide.

26 Sep 2015

H7N9 influenza vaccine failure may be due to immune camouflage, study reveals

The avian influenza A (H7N9) virus has been a major concern since the first outbreak in China in 2013. Due to its high rate of lethality and pandemic potential, H7N9 vaccine development has become a priority for public health officials. However, candidate vaccines have failed to elicit the strong immune responses necessary to protect from infection.

25 Sep 2015

HIV cure research may shift from single-therapy development model to combination therapy trials

The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published online today.

25 Sep 2015

TSRI scientists awarded grant from Gates Foundation to develop revolutionary alternative HIV/AIDS vaccine

Scientists from the Florida campus of The Scripps Research Institute have been awarded up to nearly $6 million dollars from the Bill & Melinda Gates Foundation to develop a revolutionary HIV/AIDS alternative vaccine that has demonstrated great potential in animal models.

23 Sep 2015

Novel graphene oxide-based biosensor may speed up development of new drugs against HIV, cancer

Longing to find a cure for cancer, HIV and other yet incurable diseases, researchers have already tried out hundreds of drugs, each requiring preclinical and clinical testing with live subjects. How many chemical agents more to try? Moving at such rate, will we find the cure during our lifetime? One of the easiest ways to speed up the drug development process is to simply perform it outside of the living body (e.g., by watching the substances react with the smallest pieces of live tissue and thus quickly predicting the overall effect it will make to the body when inside).

23 Sep 2015

Protein-based modular system could help detect viral infection or kill cancer cells

MIT biological engineers have developed a modular system of proteins that can detect a particular DNA sequence in a cell and then trigger a specific response, such as cell death.

22 Sep 2015

Vaginal silicone ring may protect women against HIV, herpes virus

Researchers at University Jean Monnet of Saint-Etienne, France have succeeded in developing a vaginal silicone ring that delivers molecules that act on both HIV and herpes virus. This research is presented at the 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC/ICC).

21 Sep 2015

Results from phase 3 women-only HIV study show improved safety, efficacy of Stribild drug

Results from the first phase 3 HIV study to enroll only women show improved safety and efficacy of the drug Stribild over multi-pill antiretroviral drug regimens. The research was presented at ASM's 55th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC/ICC).

21 Sep 2015

UC San Diego, TSRI form new consortium to map cells in space and time

Drawing on complementary strengths of two San Diego institutions, The Scripps Research Institute (TSRI) and the University of California, San Diego (UC San Diego) have formed a new consortium with a big mission: to map cells in space and time.

18 Sep 2015

Study shows fear and stigma are major factors that contribute to spread of AIDS, Ebola

Just weeks after Sierra Leone discharged its last patient, a new study reflects on the lessons learnt from the recent outbreak of Ebola, comparing it with that of AIDS in Africa in the early 1980s.

18 Sep 2015

Study reports use of new psychoactive drugs in US nationally representative survey

In recent years, there has been an increase in emergence and use of a variety of new drugs, so-called "novel psychoactive substances" (NPS) in the US and worldwide.

16 Sep 2015

Study: Skin microbiome can influence outcomes of chancroid

For years, researchers have known that the human skin is home to a diverse community of microorganisms, collectively known as the skin microbiome. Now a new study has shown that individuals with a particular skin microbiome can effectively clear bacteria that cause chancroid, a sexually transmitted disease common in the developing world that has been linked to enhanced HIV transmission.

16 Sep 2015

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the McGill University Health Centre and University of Alberta could be a game changer for patients, improving both quality of life and longevity.

15 Sep 2015

A Day with HIV: A new initiative to tackle stigma, discrimination against HIV patients

On one day, Tuesday, September 22nd, Positively Aware and TPAN are inviting everyone, regardless of HIV status, to get in the picture and participate in A Day with HIV, the magazine's sixth annual anti-stigma photo campaign. On 9/22/2015 people across the world, whether HIV-positive or negative, will visually capture and share a moment of their day – A Day with HIV – to focus attention on what it means to live in a world with HIV.

14 Sep 2015

HIV 1 News and Research

OJ-Bio to showcase new smartphone-enabled diagnostic testing device at Medica 2015

Unique molecule can bind HIV-infected cells to killer T cells

Specialized proteins can inhibit HIV

OJ Bio at Medica 2015 - Point of Care diagnostics' role in reducing antibiotics prescribing

Investment in radiotherapy services could save lives, boost economy in developing countries

New partnership aims to support countries in improving performance of primary health care

Creating a new paradigm for management of yeast infections

H7N9 influenza vaccine failure may be due to immune camouflage, study reveals

HIV cure research may shift from single-therapy development model to combination therapy trials

TSRI scientists awarded grant from Gates Foundation to develop revolutionary alternative HIV/AIDS vaccine

Novel graphene oxide-based biosensor may speed up development of new drugs against HIV, cancer

Protein-based modular system could help detect viral infection or kill cancer cells

Vaginal silicone ring may protect women against HIV, herpes virus

Results from phase 3 women-only HIV study show improved safety, efficacy of Stribild drug

UC San Diego, TSRI form new consortium to map cells in space and time

Study shows fear and stigma are major factors that contribute to spread of AIDS, Ebola

Study reports use of new psychoactive drugs in US nationally representative survey

Study: Skin microbiome can influence outcomes of chancroid

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

A Day with HIV: A new initiative to tackle stigma, discrimination against HIV patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News